Back to trial details

Intake questionnaire

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Applying to Imaging Endpoints · Scottsdale, Arizona

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 55 and 90 years old?
2. Have you been diagnosed with Alzheimer Disease?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Scottsdale for study visits?